FDA Panel Unclear on Osteoporosis Drug Labels
FDA Panel: Osteoporosis Drugs Need Better Labels Time Limits on the Drugs Are Suggested, but How Much Time Is Yet to Be Determined WebMD Medical News By Rita Rubin Reviewed...
Click here to read the full story.
All postings and submissions are subject to the Newport Television Terms of Use Agreement. By posting your submission, you agree that you have carefully reviewed these terms and conditions and agree to be bound therein.
You will be solely responsible for your submissions and the consequences of posting or publishing them. Newport reserves the right to decide whether a submission is appropriate and complies with its Terms of Use Agreement. Newport may remove any submission, without prior notice, for violations of the Terms of Use Agreement, including but not limited to submissions that are pornographic, obscene, indecent, defamatory, or otherwise inappropriate for public viewing.
The content has been reported and it will be reviewed by a moderator.
